Vinitha Ramanath Pai
Overview
Explore the profile of Vinitha Ramanath Pai including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
124
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mahin A, Gopalakrishnan A, Ahmed M, Nisar M, John L, Shivamurthy P, et al.
OMICS
. 2025 Mar;
PMID: 40079160
Intracellular calcium signaling is a cornerstone in cell biology and a key molecular target for human health and disease. Calcium/calmodulin dependent protein kinase kinases, CAMKK1 and CAMKK2 are serine/threonine kinases...
2.
Shetty P, Rai M, Ravindran A, Gopalakrishna H, Pai V, Kalal B
Int J Clin Exp Pathol
. 2022 Oct;
15(9):380-387.
PMID: 36237637
Background And Objectives: Diabetes mellitus, a global health problem, is associated with metabolic complications such as hyperglycemia, hyperlipidemia, hypertension, cardiovascular diseases, and loss of vision. The present study evaluated the...
3.
Dsouza J, Pai V, Harish S, Shriyan C
Indian J Clin Biochem
. 2022 Feb;
37(1):113-118.
PMID: 35125701
Sialic acid is a terminal component of carbohydrate chains of glycoproteins and glycolipids. The present study estimated total sialic acid (TSA) and its ratio with total proteins (TP), in serum...
4.
Kalal B, Modi P, Najar M, Behera S, Upadhya D, Prasad T, et al.
Am J Cancer Res
. 2022 Jan;
11(12):5881-5901.
PMID: 35018231
Drug-resistant melanoma is very difficult to treat, and a novel approach is needed to overcome resistance. The present study aims at identifying the alternate pathways utilized in the dual drug-resistant...
5.
Kalal B, Modi P, Upadhya D, Saha P, Prasad T, Pai V
Am J Transl Res
. 2021 Nov;
13(10):11081-11093.
PMID: 34786044
Background: Bone morphogenetic proteins (BMPs) are members of the transforming growth factor-β superfamily, known to promote the tumor invasion and metastasis. There are continual progresses in understanding the role of...
6.
Sharma M, Sharma E, Prabhu V, Pai V, Dsouza J, Harish S, et al.
J Cancer Res Ther
. 2020 Jul;
16(3):546-550.
PMID: 32719265
Background: The objective of this study was to evaluate the serum and salivary L-fucose in oral potentially malignant disorders (OPMDs) and oral cancer (OC) in order to investigate the possibility...
7.
Kalal B, Pai V, Behera S, Somashekarappa H
Med Sci (Basel)
. 2019 Mar;
7(3).
PMID: 30909413
Resistance to anticancer drugs limits the effectiveness of chemotherapy in cancers. Melanoma cell lines B16F10C and A375C (parental) and B16F10R and A375R (drug-resistant sublines) were used to test radiation sensitization...
8.
Anantacharya R, Satyanarayan N, Kalal B, Pai V
Open Med Chem J
. 2018 Jul;
12:73.
PMID: 30008963
No abstract available.
9.
Anantacharya R, Satyanarayan N, Kalal B, Pai V
Open Med Chem J
. 2018 Jul;
12:60-72.
PMID: 30008962
Background: Furan, quinoline and triazoles are known for their wide spectrum biologically active molecules. A series of novel furan C-2 quinoline and 1, 2, 4-triazole (FQT) coupled hybrids were designed...
10.
Bhat M, Poojary B, Kalal B, Gurubasavaraja Swamy P, Kabilan S, Kumar V, et al.
Future Med Chem
. 2018 May;
10(9):1017-1036.
PMID: 29708431
Aim: To synthesize a series of new thiazolidinone-pyrazole hybrids (5a-o) and assess their anticancer (in vitro and in vivo) and antimicrobial activities. Results: The compounds 5h (against Ehrlich ascites carcinoma...